Intermittent fasting induced ketogenesis inhibits mouse epithelial ovarian cancer by promoting antitumor T cell response
Open Access
- 9 September 2023
- Vol. 26 (10) , 107839
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- T cell metabolism drives immunityJournal of Experimental Medicine, 2015
- A metabolomic approach to identifying platinum resistance in ovarian cancerJournal of Ovarian Research, 2015
- Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexiaCancer & Metabolism, 2014
- Calorie Restriction Decreases Murine and Human Pancreatic Tumor Cell Growth, Nuclear Factor-κB Activation, and Inflammation-Related Gene Expression in an Insulin-like Growth Factor-1−Dependent MannerPLOS ONE, 2014
- Ketone supplementation decreases tumor cell viability and prolongs survival of mice with metastatic cancerInternational Journal of Cancer, 2014
- Fasting Cycles Retard Growth of Tumors and Sensitize a Range of Cancer Cell Types to ChemotherapyScience Translational Medicine, 2012
- Ketone bodies inhibit the viability of human neuroblastoma cellsJournal of Pediatric Surgery, 2009
- Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cellsEuropean Journal of Immunology, 2008
- (d)-β-Hydroxybutyrate Inhibits Adipocyte Lipolysis via the Nicotinic Acid Receptor PUMA-GJournal of Biological Chemistry, 2005
- Calorie Restriction, Aging, and Cancer Prevention: Mechanisms of Action and Applicability to HumansAnnual Review of Medicine, 2003